- Graduate School - Washington University School of Medicine (2008-2010)
- Fellowship - Washington University School of Medicine (2006-2009), Pulmonary Diseases & Critical Care Medicine
- Residency - UT Southwestern Medical Center (2004-2005), Internal Medicine
- Residency - UT Southwestern Medical Center (2001-2004), Internal Medicine
- Medical School - UT Health Science Center at Houston (1997-2001)
- Other Post Graduate Training - Washington University School of Medicine (2008-2010)
- Graduate School - Washington University School of Medicine (2008-2010), Clinical Investigation
Raksha Jain, M.D.
- Dedman Family Scholar in Clinical Care
- Internal Medicine - Pulmonary Disease
- Lung (Pulmonary) Disorders
- Cystic Fibrosis
Raksha Jain, M.D., is an Associate Professor in UT Southwestern Medical Center's Department of Internal Medicine and is a Dedman Family Scholar in Clinical Care. She is also the Medical Director of the Adult Cystic Fibrosis Program.
She has earned awards from the National Institutes of Health, Children’s Medical Center of Dallas, and the Cystic Fibrosis Foundation for her work on hormonal influences of lung disease in cystic fibrosis.
Dr. Jain obtained her bachelor of science degree at the Massachusetts Institute of Technology in molecular biology and received her medical degree at the University of Texas Houston Health Science Center. She completed her residency and chief residency in internal medicine at UT Southwestern and moved to Washington University in St. Louis for her fellowship in pulmonary and critical care medicine.
She oversees multicenter clinical trials related to cystic fibrosis and conducts her own clinical and molecular scientific research. Her research interests include new treatments for cystic fibrosis and gender disparities in airway diseases.
Dr. Jain is board certified in pulmonology, critical care medicine, and internal medicine by the American Board of Internal Medicine.
Meet Dr. Jain
Cystic Fibrosis Specialist
As Director of UT Southwestern Medical Center's Adult Cystic Fibrosis Program, pulmonologist Raksha Jain, M.D., is dedicated to providing – and developing – the most effective treatment plan for her patients.
Thanks to recent advancements such as gene mutation targeted therapies, she can offer more options than ever to help cystic fibrosis (CF) patients overcome issues such as malnutrition and recurrent respiratory infections.
Dr. Jain sees her patients on a regular basis and manages their CF care in the clinic and in the hospital.
"We don't just take care of their lungs,” Dr. Jain says. “We take care of their sinuses, their pancreatic and digestive problems, and their diabetes with help from our multi-disciplinary CF team."
It creates a strong bond that extends beyond a typical doctor-patient relationship. "We meet their families, and we know where they go to school and who they are married to," Dr. Jain says. "We really grow to know and care about our patients tremendously."
By choosing Dr. Jain and UT Southwestern for their care, CF patients benefit from a large center that has the resources to provide the best treatments, including lung transplantation. The lung transplant program at UT Southwestern has ranked in the top 10 in the United States for many years.
UT Southwestern is accredited by the Cystic Fibrosis Foundation, a designation that means Dr. Jain and her team meet the highest standards of care.
Dr. Jain is also active in clinical and molecular scientific research to help improve future care for patients with CF. Dr. Jain is co-principal investigator on the Cystic Fibrosis Foundation Therapeutics Development Network grant, which helps provide the infrastructure for conducting clinical trials to evaluate the safety and effectiveness of new CF therapies.
Her efforts to bring cystic fibrosis clinical trials to UT Southwestern mean that patients have easier access to the latest potential treatments – an option that they may have had to travel long distances for in the past.
"We offer many exciting new therapies to cystic fibrosis patients."
- Texas Medical Association
- Dallas County Medical Society
- American Thoracic Society
- American College of Chest Physicians
- Association for Clinical and Translational Science (2009)
- Society for Women's Health Research (2012)
- D Magazine Best Doctor 2020
- CFF Foundation Harry Shwachman Clinical Research Award 2015-2018
- LEAD Capstone Dean's Recognition Award - U.T. Southwestern Medical Center 2015
- CREW award recipient 2010
- Dedman Family Scholar in Clinical Care 2010
- Multidisciplinary Clinical Research Career Development Award 2009
- American Thoracic Society Career Development Award 2009
- University of Texas Houston Health Science Center Gold Headed Cane Award 2001, Humanism in Medicine
AcrAB-TolC Inhibition by Peptide-conjugated Phosphorodiamidate Morpholino Oligomers Restores Antibiotic Activity in vitro and in vivo.
Sturge CR, Felder-Scott CF, Pifer R, Pybus C, Jain R, Geller B, Greenberg D, ACS infectious diseases 2019 May
Impact of high- versus low-risk genotype on sinonasal radiographic disease in cystic fibrosis.
Halderman AA, Lee S, London NR, Day A, Jain R, Moore JA, Lin SY The Laryngoscope 2018 Dec
Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.
Jain R, Hachem RR, Morrell MR, Trulock EP, Chakinala MM, Yusen RD, Huang HJ, Mohanakumar T, Patterson GA, Walter MJ The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2010 May 29 5 531-7
Temporal relationship between primary and motile ciliogenesis in airway epithelial cells.
Jain R, Pan J, Driscoll JA, Wisner JW, Huang T, Gunsten SP, You Y, Brody SL American journal of respiratory cell and molecular biology 2010 Dec 43 6 731-9
Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1.
Jain R, Shaul PW, Borok Z, Willis BC American journal of respiratory cell and molecular biology 2007 Jul 37 1 38-47
Bronchorrhoea complicating inflammatory bowel disease.
Jain R, Scheurich D, Lindberg GM, Girod CE Thorax 2006 Nov 61 11 1014
Pharmacological therapy for acute respiratory distress syndrome.
Jain R, DalNogare A, Mayo Clinic proceedings 2006 Feb 81 2 205-12
Jain R, Rosenbluth DR The Washington Manual: Pulmonary Subspeciality Consult 2010 2010 341-348
Sex Hormone-Dependent Regulation of Cilia Beat Frequency in Airway Epithelium.
Jain R, Ray JM, Pan JH, Brody SL American journal of respiratory cell and molecular biology 2011 Oct
Sensory functions of motile cilia and implication for bronchiectasis.
Jain R, Javidan-Nejad C, Alexander-Brett J, Horani A, Cabellon MC, Walter MJ, Brody SL Frontiers in bioscience (Scholar edition) 2012 4 1088-98
Effects of puberty on cystic fibrosis related pulmonary exacerbations in women versus men.
Sutton S, Rosenbluth D, Raghavan D, Zheng J, Jain R Pediatric pulmonology 2013 Mar
Gender differences in outcomes of patients with cystic fibrosis.
Harness-Brumley CL, Elliott AC, Rosenbluth DB, Raghavan D, Jain R Journal of women's health (2002) 2014 Dec 23 12 1012-20
Increasing awareness of sex differences in airway diseases.
Raghavan D, Jain R Respirology (Carlton, Vic.) 2015 Dec
Lung transplantation and gender effects on survival of recipients with cystic fibrosis.
Raghavan D, Gao A, Ahn C, Kaza V, Finklea J, Torres F, Jain R The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2016 Jun
Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial.
Heubi JE, Schaeffer D, Ahrens RC, Sollo N, Strausbaugh S, Graff G, Jain R, Witte S, Forssmann K The Journal of pediatrics 2016 Jun
Evaluating Outcomes Disparities in the Hispanic Cystic Fibrosis Population: A Need for a National Analysis.
Rho J, Ahn C, Gao A, Keller A, Jain R Chest 2016 Sep 150 3 751-3
Standardized Treatment of Pulmonary exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary exacerbations.
West NE, Beckett VV, Jain R, Sanders DB, Nick JA, Heltshe SL, Dasenbrook EC, VanDevanter DR, Solomon GM, Goss CH, Flume PA Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2017 Apr
17ß-estradiol dysregulates innate immune responses to Pseudomonas aeruginosa respiratory infection and is modulated by estrogen receptor antagonism.
Abid S, Xie S, Bose M, Shaul PW, Terada LS, Brody SL, Thomas PJ, Katzenellenbogen JA, Kim SH, Greenberg DE, Jain R Infection and immunity 2017 Aug
Eosinophilic Lung Disease Associated with Non-Hodgkin’s Lymphoma. A Case Report and Review of the Literature.
Jain R, Katz JN, Amirkhan RH, Glazer C Clinical Pulmonary Medicine January 2007 14 13-16
- AcrAB-TolC Inhibition by Peptide-conjugated Phosphorodiamidate Morpholino Oligomers Restores Antibiotic Activity in vitro and in vivo.
- Treatment advances for Cystic Fibrosis
- Sex hormone influence on host immunity
- Gender disparities in lung diseases
- Lung (Pulmonary) Disorders
- Cystic Fibrosis
Q&A by Dr. Jain
Dr. Jain on Cystic Fibrosis
Dr. Jain explains how new therapies and great care are helping patients with cystic fibrosis lead longer and healthier lives.